VRAY - ViewRay, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

ViewRay, Inc.

2 Thermo Fisher Way
Bedford, OH 44146
United States

IndustryMedical Appliances & Equipment
Full Time Employees139

Key Executives

NameTitlePayExercisedYear Born
Mr. Chris A. RaanesPres, CEO & Director622.5kN/A1965
Mr. Ajay BansalCFO & Principal Accounting Officer295.26kN/A1962
Dr. James F. Dempsey Ph.D.Chief Scientific Officer & Director351kN/A1971
Mr. Douglas H. KeareChief Operating OfficerN/AN/A1964
Mary E. O'ByrneVP & Chief CounselN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ViewRay, Inc., through its subsidiary, ViewRay Technologies, Inc., designs, manufactures, and markets radiation therapy systems. It offers MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient's anatomy simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the location and shape of soft-tissue tumors while radiation is delivered. Its customers include university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. The company markets its MRIdian through a direct sales force in the United States, as well as through distributors internationally. ViewRay, Inc. was founded in 2004 and is headquartered in Oakwood Village, Ohio.

Corporate Governance

ViewRay, Inc.’s ISS Governance QualityScore as of March 1, 2018 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.